Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Sales 3,247,010 2,976,970 4,133,300 18,238,449 22,451,330
Sales Growth +9.07% -27.98% -77.34% -18.76% +3,974.95%
Net Income -1,285,380 -719,920 1,006,860 9,940,080 12,177,060
Net Income Growth -78.54% -171.50% -89.87% -18.37% +70,044.35%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Total Assets 24,877,900 24,379,391 24,899,721 24,526,859 18,729,420
Total Assets Growth +2.04% -2.09% +1.52% +30.95% +607.15%
Total Liabilities 3,127,640 3,374,640 2,987,580 3,396,280 4,657,980
Total Liabilities Growth -7.32% +12.96% -12.03% -27.09% +330.70%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Operating Cash Flow 515,920 224,750 5,813,470 14,305,150 1,052,600
Operating Cash Flow Growth +129.55% -96.13% -59.36% +1,259.03% +6,939.51%
Net Cash Flow -2,360,670 -2,057,940 -2,393,400 12,835,380 570,850
Change in Net Cash Flow -14.71% +14.02% -118.65% +2,148.47% -27.69%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.